Furthermore, we found that recombinant BMP13 induces the expression of ID1 and ID2 in a dose-dependent manner in HCC cells, and that BMP13 represses the expression of CDKN1A (p21) and CDKN2A (p16) in HCC cells. This evidence concerns the gene ID2 and hepatocellular carcinoma.